Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

PProtagonist Therapeutics, Inc

EconomyAI buildoutMarket MapFundsWatchlist
Log in
P

Protagonist Therapeutics, Inc

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Protagonist at the Cantor Global Healthcare Conference
    Sep 18, 2026protagonist-inc
  • Protagonist at the Cantor Global Healthcare Conference
    Sep 18, 2026protagonist-inc
  • Protagonist at the Citi Biopharma Back to School Summit
    Sep 9, 2026protagonist-inc
  • Protagonist at the Citi Biopharma Back to School Summit
    Sep 9, 2026protagonist-inc
  • Corporate Presentation
    Sep 8, 2026protagonist-inc

    September 8, 2026

  • Corporate Presentation
    Sep 8, 2026protagonist-inc

    September 8, 2026

  • US FDA Approval of MIMRYLO™(rusfertide) for Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)
    Aug 31, 2026protagonist-inc
  • US FDA Approval of MIMRYLO™(rusfertide) for Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)
    Aug 31, 2026protagonist-inc
  • U.S. FDA Approves MIMRYLO™ (rusfertide)
    Aug 28, 2026protagonist-inc
  • U.S. FDA Approves MIMRYLO™ (rusfertide)
    Aug 28, 2026protagonist-inc
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions